[¿Â¶óÀÎ] 2021 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ : 2021-11-11±³À°ÀÏÀÚ : 2021-11-11
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
[¿Â¶óÀÎ] 2021 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 3Á¡ (ÀÏ¹Ý 2Á¡ / Çʼö 1Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 A 17:00~18:00 COVID-19 vaccine related hematologic manifestations ¹æ¼ö¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 A 18:00~18:40 Position of Romiplostim in AA(Aplastic Anemia) treatment ÀåÁöÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 A 18:40~19:20 Second transplantation in multiple myeloma ÀÌÀ¯Áø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 A 19:20~20:00 CML(Chronic Myelogenous Leukemia) in children and adolescents À¯Àç¿ø(°¡Å縯ÀÇ´ë)